Cited by 207Mitochondrial Function and PathologyMuscle Physiology and DisordersImmune Response and Inflammation

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index; none of the 37 sources its claims cite is checked for support yet.

Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency

Open access

Abstract

Opa1 participates in inner mitochondrial membrane fusion and cristae morphogenesis. Here, we show that muscle-specific Opa1 ablation causes reduced muscle fiber size, dysfunctional mitochondria, enhanced Fgf21, and muscle inflammation characterized by NF-κB activation, and enhanced expression of pro-inflammatory genes. Chronic sodium salicylate treatment ameliorated muscle alterations and reduced the muscle expression of Fgf21. Muscle inflammation was an early event during the progression of the disease and occurred before macrophage infiltration, indicating that it is a primary response to Opa1 deficiency. Moreover, Opa1 repression in muscle cells also resulted in NF-κB activation and inflammation in the absence of necrosis and/or apoptosis, thereby revealing that the activation is a cell-autonomous process and independent of cell death. The effects of Opa1 deficiency on the expression NF-κB target genes and inflammation were absent upon mitochondrial DNA depletion. Under Opa1 deficiency, blockage or repression of TLR9 prevented NF-κB activation and inflammation. Taken together, our results reveal that Opa1 deficiency in muscle causes initial mitochondrial alterations that lead to TLR9 activation, and inflammation, which contributes to enhanced Fgf21 expression and to growth impairment.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Muscle-specific loss of Opa1 in mice produces mitochondrial dysfunction, mtDNA stress, and a primary inflammatory response that precedes macrophage infiltration and contributes to growth impairment. The inflammatory NF-κB program depends on mtDNA and TLR9, and anti-inflammatory salicylate treatment partially rescues muscle and growth phenotypes.

Key findings

  • Opa1 ablation in skeletal muscle shortened lifespan, reduced body growth, muscle weight, grip strength, and myofiber cross-sectional area, and altered the GH/IGF1 axis; muscle Fgf21 was strongly induced and circulating Fgf21 was about fourfold higher.
  • Inflammation appeared early: IL-1β labeling was already elevated at 3 weeks, while CD68-positive macrophages were not detected until 13 weeks; NF-κB target genes and plasma IL-1β/IL-6 were increased.
  • Opa1 deficiency caused mitochondrial fragmentation, reduced respiration, increased glycolysis, and mtDNA stress, including roughly 50% lower mtDNA copy number, about half the TFAM protein, fewer nucleoids, and larger nucleoids.
  • The inflammatory response required mtDNA and TLR9: ethidium bromide treatment depleted mtDNA by more than 95% and abolished NF-κB target gene induction, while TLR9 antagonism or TLR9 knockdown reduced NF-κB target genes and IL-6 release; mtDNA co-localized with TLR9 in over 50% of signal.

Methods

  • Mouse models included muscle-specific Opa1 knockout via Opa1-loxP/loxP crossed with myogenin-Cre, tamoxifen-inducible adult muscle Opa1 knockout, cardiotoxin injury with adenoviral Opa1 miRNA, and Opa1/Fgf21 double knockout; treatments included sodium salicylate and chloroquine.
  • Cell studies used C2C12 myoblasts with Opa1 knockdown, ethidium bromide-mediated mtDNA depletion, cGAS or TLR9 knockdown, and ODN2088 TLR9 antagonist treatment.
  • Analyses included histology, immunofluorescence, electron microscopy, mitochondrial respiration, Seahorse extracellular flux, ATP measurement, mtDNA quantification, Western blotting, plasma cytokine/hormone assays, gene expression, and t-tests or ANOVA with post hoc tests at P < 0.05.

Limitations

  • The paper states that mitophagy measurements are difficult in skeletal muscle and that further work is needed to document Opa1’s impact on muscle mitophagy.
  • The paper states that the precise mechanism by which mtDNA interacts with TLR9 remains unclear, that robust demonstration is lacking, and that mitochondria-derived vesicle involvement cannot be excluded.
  • The paper notes that localization of mtDNA or mitochondria to late endosomes could not be concluded because triple staining was lacking; more broadly, the evidence is largely from mouse and C2C12 models, with human inflammatory myopathy relevance proposed rather than directly tested.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.15252/embj.201796553

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 37 cited sources checked · 0 supported · 0 flagged

Show all 92 claims

  • It may state two separate claims as one. 55
  • Probably not a substantial claim. 13
64 of 64
  • The paper relies on this without support.

    CD68 staining specifically marks pro-inflammatory macrophages in this muscle context.

    “pro-inflammatory macrophages (stained for CD68)”
    “a marker of macrophage infiltration”
  • The paper relies on this without support.

    IL-1b labeling indicates inflammation in muscle.

    “Highly positive labeling for IL-1b was already detected at 3 weeks in Opa1-deficient muscles”
  • The paper relies on this without support.

    Ethidium bromide treatment depletes mtDNA without affecting other cellular processes relevant to NF-kB target gene expression.

    “We depleted mtDNA in C2C12 muscle cells by chronic treatment with ethidium bromide (EtBr).”
  • The paper relies on this without support.

    ODN2088 specifically antagonizes TLR9 in these cells.

    “cells were treated with the TLR9 antagonist ligand ODN2088 or with the corresponding negative control.”
  • The paper relies on this without support.

    Chloroquine effectively inhibits lysosomal degradation in muscle and muscle cells.

    “treatment for 5 days with chloroquine caused a marked buildup of the autophagic protein LC3-II in muscles from control mice”
  • The paper relies on this without support.

    CCCP induces mitochondrial depolarization and mitophagy in these cells.

    “Mitochondrial autophagy was analyzed upon treatment of control of Opa1-deficient muscle cells with the depolarizing agent CCCP.”
  • The paper relies on this without support.

    p62 accumulation reflects impaired autophagic flux in muscle.

    “Time-course studies revealed significantly increased levels of p62”
7 of 7

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Flagged first, then by citations

Show all 65 references

1 of the 65 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

See all 207

Metadata

Authors
Rodríguez‐Nuevo, A., Díaz‐Ramos, A., Noguera, E., Díaz‐Sáez, F., Duran, X., Muñoz, J. P., Romero, M., Plana, N., Sebastián, D., Tezze, C., Romanello, V., Ribas, F., Seco, J., Planet, E., Doctrow, S. R., González, J., Borràs, M., Liesa, M., Palacín, M., Vendrell, J., Villarroya, F., Sandri, M., Shirihai, O., & Zorzano, A.
Affiliations
  • Instituto de Salud Carlos III (ES)
  • Universitat de Barcelona (ES)
  • Veneto Institute of Molecular Medicine (IT)
  • Institute for Research in Biomedicine (ES)
  • Boston University (US)
  • Parc Científic de Barcelona (ES)
  • University of California, Los Angeles (US)
Venue
The EMBO Journal
Published
2018-04-06
Volume
37
Issue
10
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2796990937
Cited by
207
References
65
Citations by year
2026: 11 · 2025: 24 · 2024: 26 · 2023: 32 · 2022: 24 · 2021: 40 · 2020: 30 · 2019: 13 · 2018: 6
FWCI
7.87
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, other-oa)
Funders
  • “Ministerio de Educación y Cultura,” Spain
  • Fundación Isabel Gemio
  • FEDER y ASEM, Instituto de Salud Carlos III (PIE14/00045)
  • INTERREG IV‐B‐SUDOE‐FEDER (SOE1/P1/E178)
  • Ministerio de Economía y Competitividad (SAF2013‐40987R, SAF2016‐75246R)
  • Generalitat de Catalunya (2014SGR48)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
OPA1, mitochondrial DNA, TLR9, muscle inflammation, skeletal muscle, NF-κB activation, FGF21, mitochondrial fusion, muscle fiber size, growth retardation, sodium salicylate
MeSH terms
Animals, Cells, Cultured, DNA, Mitochondrial, Female, Inflammation, Male, Muscular Diseases, Necrosis, Regeneration, Cytokines, Apoptosis, Mice, Knockout, Muscle, Skeletal, GTP Phosphohydrolases, Toll-Like Receptor 9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review